Company intelligence / Profile preview

MEKICS

Paju-si, Gyeonggi-do, South Koreamek-ics.com ↗
Ownership
Private
Employees
~123
Development stage
Other
01

Overview

MEKICS has commercialized a range of advanced ventilators and patient monitoring systems. The company was the first in Korea to develop both ventilators and CPAP devices for critical care and neonatal use. Its products are widely used in hospitals for respiratory therapy and intensive care.

Therapeutic areas
PulmonologyOther
Modalities
Device (ventilators, patient monitors)Non-pharmacological therapy (respiratory support devices)
Industry
Therapeutic Medical Devices
02

Partnerships

BIOLASE (ventilator manufacturing partnership during COVID pandemic)

Beyond the preview

Go deeper on MEKICS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEKICS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call